- Efficacy, Safety, and Pharmacokinetics of Beroctocog Alfa in Patients Previously Treated for Hemophilia A
-
Hyun SY, Park SY, Lee SY, Kook H, Paik SH, Jang IJ, Lee KS
- KMID: 2366332
- Yonsei Med J.
- 2015 Jul;56(4):935-943.
- doi: 10.3349/ymj.2015.56.4.935
PURPOSE: Beroctocog alfa is a second generation recombinant factor VIII manufactured by removing the B-domain from factor VIII. This prospective clinical trial was conducted to evaluate the efficacy, safety, and... -
- CITED
-
- Close
- SHARE
-
- Close
